Skip to content

Clinical trials

Observational Overweight trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Observational Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20141
20181
20191
20202
20211
20231
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Not yet recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center4
Amsterdam UMC, location VUmc1
Catharina Ziekenhuis Eindhoven1
HAN University of Applied Sciences1
Novo Nordisk A/S1
Radboud University Medical Center1
Rijnstate Hospital1
TNO1
Universitaire Ziekenhuizen KU Leuven1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight13
Obesity12
Pediatric Obesity3
Insulin Resistance2
Weight Loss2
COVID-191
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Diabetes, Gestational1
Gestational Weight Gain1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.